VYCOR MEDICAL, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | $1.5M | $1.1M | $1.3M | $1.1M | $1.2M | $971.4K | $316.5K |
| Cost of Revenue | $227.1K | $184.7K | $164.1K | $156.3K | $153.8K | $179.5K | $176.3K | $48.7K |
| Gross Profit | $1.2M | $1.3M | $974.5K | $1.1M | $935.5K | $1.0M | $795.1K | $267.7K |
| Gross Margin | 83.6% | 87.3% | 85.6% | 87.5% | 85.9% | 85.1% | 81.9% | 84.6% |
| Operating Expenses | ||||||||
| Research & Development | $3.0K | $4.7K | $71.5K | $69.1K | $53.5K | $126.0K | $115.7K | $15.2K |
| SG&A Expense | $2.2M | $2.6M | $2.5M | $3.4M | $2.8M | $3.4M | $5.0M | $1.9M |
| Operating Income | $-1.3M | $-1.6M | $-2.0M | $-2.7M | $-2.3M | $-2.8M | $-4.6M | $-1.9M |
| Operating Margin | -94.8% | -109.5% | -174.9% | -218.5% | -209.4% | -231.8% | -476.4% | -611.7% |
| Interest Expense | — | — | — | — | — | $137.9K | $127.1K | $45.9K |
| Pretax Income | $1.5M | $-1.7M | $-2.1M | $-4.0M | $-2.4M | $-2.9M | $-4.8M | $-2.0M |
| Income Tax Expense | — | — | — | — | — | — | — | $2.2K |
| Net Income | $-1.5M | $-1.7M | $-2.1M | $-4.0M | $-2.4M | $-2.9M | $-4.8M | $-2.0M |
| Net Margin | -106.6% | -113.7% | -182.9% | -323.9% | -224.4% | -243.2% | -491.9% | -626.9% |
| EPS (Basic) | $-0.10 | $-0.17 | $-0.20 | $-0.39 | $-0.39 | $-0.52 | $-0.92 | $0.00 |
| EPS (Diluted) | $-0.10 | $-0.17 | $-0.20 | $-0.39 | $-0.39 | $-0.52 | $-0.92 | $0.00 |
| Shares Outstanding (Basic) | 19.8M | 11.3M | 10.9M | 10.8M | 6.6M | 6.0M | 807.2M | 724.5M |
| Shares Outstanding (Diluted) | 19.8M | 11.3M | 10.9M | 10.8M | 6.6M | 6.0M | 807.2M | 724.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |